Role of osteopontin in early phase of renal crystal formation: Immunohistochemical and microstructural comparisons with osteopontin knock-out mice

Urological Research

Volumn 40, Issue 2, 2012, Pages 121-129

  Hirose, Masahito ^a   Tozawa, Keiichi ^a   Okada, Atsushi ^a   Hamamoto, Shuzo ^a   Higashibata, Yuji ^a   Gao, Bin ^b,c   Hayashi, Yutaro ^a   Shimizu, Hideo ^a   Kubota, Yasue ^a   Yasui, Takahiro ^a   Kohri, Kenjiro ^a  

^a NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^b SHENYANG MEDICAL COLLEGE   (China)

^c China Japan Kidney Stone Research Center   (China)

Author keywords

Glyoxylate Electron microscopy; Osteopontin Osteopontin knock out mice; Renal stone

Indexed keywords

GLYOXYLIC ACID; MESSENGER RNA; OSTEOPONTIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL ULTRASTRUCTURE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; IMMUNOHISTOCHEMISTRY; KIDNEY CORTEX; KIDNEY DISTAL TUBULE; KIDNEY MEDULLA; MALE; MICROSCOPY; MICROVILLUS; MITOCHONDRION; MOUSE; NEPHROLITHIASIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STONE FORMATION; TRANSMISSION ELECTRON MICROSCOPY; WESTERN BLOTTING;

ANIMALS; CALCIUM OXALATE; CRYSTALLIZATION; GLYOXYLATES; KIDNEY; KIDNEY CALCULI; KIDNEY TUBULES, DISTAL; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICROSCOPY, ELECTRON, TRANSMISSION; MICROVILLI; MITOCHONDRIA; ORGANELLES; OSTEOPONTIN; TIME FACTORS;

EID: 84863717190     PISSN: 03005623     EISSN: 14340879     Source Type: Journal    
DOI: 10.1007/s00240-011-0400-z     Document Type: Article

References (43)

1. Kulaksizoglu S, Sofikerim M, Cevik C (2007) Impact of various modifiers on calcium oxalate crystallization. Int J Urol 14:214-218
2. Mo L, Liaw L, Evan AP et al (2007) Renal calcinosis and stone formation in mice lacking osteopontin, Tamm-Horsfall protein, or both. Am J Physiol Renal Physiol 293:1935-1943
3. Khan SR (2004) Crystal-induced inflammation of the kidneys: results from human studies, animal models, and tissue-culture studies. Clin Exp Nephrol 8:75-88
4. Canales BK, Anderson L, Higgins L et al (2008) Second prize: comprehensive proteomic analysis of human calcium oxalate monohydrate kidney stone matrix. J Endourol 22:1161-1167
5. Merchant ML, Cummins TD, Wilkey DW et al (2008) Proteomic analysis of renal calculi indicates an important role for inflammatory processes in calcium stone formation. Am J Physiol Renal Physiol 295:F1254-F1258
6. Kohri K, Suzuki Y, Yoshida K et al (1992) Molecular cloning and sequencing of cDNA encoding urinary stone protein, which is identical to osteopontin. Biochem Biophys Res Commun 184:859-864
7. O'Brien ER, Garvin MR, Stewart DK et al (1994) Osteopontin is synthesized by macrophage, smooth muscle, and endothelial cells in primary and restenotic human coronary atherosclerotic plaques. Arterioscler Thromb 14:1648-1656
8. Giachelli CM, Lombardi D, Johnson RJ et al (1998) Evidence for a role of osteopontin in macrophage infiltration in response to pathological stimuli in vivo. Am J Pathol 152:353-358
9. Liaw L, Birk DE, Ballas CB et al (1998) Altered wound healing in mice lacking a functional osteopontin gene (spp1). J Clin Invest 101:1468-1478
10. Ophascharoensuk V, Giachelli CM, Gordon K et al (1999) Obstructive uropathy in the mouse: role of osteopontin in interstitial fibrosis and apoptosis. Kidney Int 56:571-580
11. Scatena M, Almeida M, Chaisson ML et al (1998) NF-kappaB mediates alphavbeta3 integrin-induced endothelial cell survival. J Cell Biol 141:1083-1093
12. Brown LF, Berse B, Van de Water L et al (1992) Expression and distribution of osteopontin in human tissues: widespread association with luminal epithelial surfaces. Mol Biol Cell 3:1169-1180
13. Kleinman JG, Beshensky A, Worcester EM et al (1995) Expression of osteopontin, a urinary inhibitor of stone mineral crystal growth, in rat kidney. Kidney Int 47:1585-1596
14. Itoh Y, Yasui T, Okada A et al (2005) Examination of the antioxidative effect in renal tubular cells and apoptosis by oxidative stress. Urol Res 33:261-266
15. Kohri K, Nomura S, Kitamura Y et al (1993) Structure and expression of the mRNA encoding urinary stone protein (osteopontin). J Biol Chem 268:15180-15184
16. Pampena DA, Robertson KA, Litvinova O et al (2004) Inhibition of hydroxyapatite formation by osteopontin phosphopeptides. Biochem J 378:1083-1087
17. O'Brien KD, Kuusisto J, Reichenbach DD et al (1995) Osteopontin is expressed in human aortic valvular lesions. Circulation 92:2163-2168
18. Srivatsa SS, Harrity PJ, Maercklein PB et al (1997) Increased cellular expression of matrix proteins that regulate mineralization is associated with calcification of native human and porcine xenograft bioprosthetic heart valves. J Clin Invest 99: 996-1009
19. Ikeda T, Shirasawa T, Esaki Y et al (1993) Osteopontin mRNA is expressed by smooth muscle-derived foam cells in human atherosclerotic lesions of the aorta. J Clin Invest 92: 2814-2820
20. Wada T, McKee MD, Steitz S et al (1999) Calcification of vascular smooth muscle cell cultures: inhibition by osteopontin. Circ Res 84:166-178
21. Kleinman JG, Beshensky A, Worcester EM et al (1995) Expression of osteopontin, a urinary inhibitor of stone mineral crystal growth, in rat kidney. Kidney Int 47:1585-1596
22. Asplin JR, Arsenault D, Parks JH et al (1998) Contribution of human uropontin to inhibition of calcium oxalate crystallization. Kidney Int 53:194-199
23. Min W, Shiraga H, Chalko C et al (1998) Quantitative studies of human urinary excretion of uropontin. Kidney Int 53:189-193
24. Nishio S, Hatanaka M, Takeda H et al (2000) Calcium phosphate crystal-associated proteins: alpha2-HS-glycoprotein, prothrombin F1, and osteopontin. Mol Urol 4:383-390
25. Nishio S, Hatanaka M, Takeda H et al (1999) Analysis of urinary concentrations of calcium phosphate crystal-associated proteins: alpha2-HS-glycoprotein, prothrombin F1, and osteopontin. J Am Soc Nephrol 10:394-396
26. Yamate T, Kohri K, Umekawa T et al (1996) The effect of osteopontin on the adhesion of calcium oxalate crystals to Madin-Darby canine kidney cells. Eur Urol 30:388-393
27. Lieske JC, Leonard R, Toback FG (1995) Adhesion of calcium oxalate monohydrate crystals to renal epithelial cells is inhibited by specific anions. Am J Physiol 268:F604-F612
28. Yamate T, Kohri K, Umekawa T et al (1998) Osteopontin antisense oligonucleotide inhibits adhesion of calcium oxalate crystals in Madin-Darby canine kidney cell. J Urol 160:1506-1512
29. McKee MD, Nanci A, Khan SR (1995) Ultrastructural immunodetection of osteopontin and osteocalcin as major matrix components of renal calculi. J Bone Miner Res 10:1913-1929
30. Ryall RL, Grover PK, Thurgood LA et al (2007) The importance of a clean face: the effect of different washing procedures on the association of Tamm-Horsfall glycoprotein and other urinary proteins with calcium oxalate crystals. Urol Res 35:1-14
31. Okada A, Nomura S, Saeki Y et al (2008) Morphological conversion of calcium oxalate crystals into stones is regulated by osteopontin in mouse kidney. J Bone Miner Res 23:1629-1637
32. Hamamoto S, Nomura S, Yasui T et al (2009) Effects of impaired functional domains of osteopontin on renal crystal formation: analyses of OPN-transgenic and OPN-knockout mice. J Bone Miner Res 25:2712-2723
33. Umekawa T, Yamate T, Amasaki N et al (1995) Osteopontin mRNA in the kidney on an experimental rat model of renal stone formation without renal failure. Urol Int 55:6-10
34. Umekawa T, Kohri K, Kurita T et al (1995) Expression of osteopontin messenger RNA in the rat kidney on experimental model of renal stone. Biochem Mol Biol Int 35:223-230
35. Hoyer JR, Otvos L Jr, Urge L (1995) Osteopontin in urinary stone formation. Ann N Y Acad Sci 760:257-265
36. Umekawa T (1999) Structural characteristics of osteopontin for calcium oxalate crystal. Jpn J Urol 90:436-444
37. Ryall RL, Chauvet MC, Grover PK (2005) Intracrystalline proteins and urolithiasis: a comparison of the protein content and ultrastructure of urinary calcium oxalate monohydrate and dihydrate crystals. BJU Int 96:654-663
38. Kleinman JG, Wesson JA, Hughes J (2004) Osteopontin and calcium stone formation. Nephron Physiol 98:43-47
39. Evan AP, Coe FL, Rittling SR et al (2005) Apatite plaque particles in inner medulla of kidneys of calcium oxalate stone formers: osteopontin localization. Kidney Int 68:145-154
40. Hirose M, Yasui T, Okada A et al (2009) Renal tubular epithelial cell injury and oxidative stress induce calcium oxalate crystal formation in mouse kidney. Int J Urol 17:83-92
41. Hirose M, Tozawa K, Okada A et al (2008) Glyoxylate induces renal tubular cell injury and microstructural changes in experimental mouse. Urol Res 36:139-147
42. Vernon HJ, Osborne C, Tzortzaki EG et al (2005) Aprt/Opn double knockout mice: osteopontin is a modifier of kidney stone disease severity. Kidney Int 68:938-947
43. Nakamura I, Duong le T, Rodan SB et al (2007) Involvement of alpha(v)beta3 integrins in osteoclast function. J Bone Miner Metab 25:337-344